Daily Equity Reports 18 Jan 2019

1. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 DAILY EQUITY REPORT 18 THJANUARY 2019 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

2. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report INDIAN FACE INDIAN MARKET CLOSE PREVIOUS ! INDIAN EQUITY BENCHMARK The Sensex was up 52.79 points at 36374.08, while Nifty was up 14.90 points at 10,905.20. About 1046 shares have advanced, 1496 shares declined, and 173 shares are unchanged. GLOBAL FACE NIFTY ASIAN MARKET CLOSE PREVIOUS NIKKEI ! Asian Market - Asian markets finished lower today with shares in Hong Kong leading the region. The Hang Seng is down 0.65% while China's Shanghai Composite is off 0.42% 2107.06 2106.10 SECTORIAL INDICES and Japan's Nikkei 225 is lower by 0.20%. CLOSE CHANGE (%) ! U.S. Market – North and South American markets finished higher on Wednesday with shares in Mexico leading the CNX 100 0.11 S&P CNX 500 9161.60 0.06 region. The IPC is up 0.50% while Brazil's Bovespa is up 0.36% and U.S.'s S&P 500 is up 0.22%. 4875.60 -0.30 CNX 200 5752.45 0.06 ! .BANK NIFTY 0.16 European markets - - European markets are lower today with shares in France off the most. The CAC 40 is down 0.44% while Germany's DAX is off 0.41% and London's FTSE 100 is TOP GAINERS CLOSE CHANGE (%) lower by 0.40%. 2.23 GAIL 332.75 1.99 BPCL 354.15 1.78 INFRATEL 280.75 1.64 AXISBANK 674.90 TOP LOSERS CLOSE CHANGE (%) SUNPHARMA 423.80 YESBANK 200.65 ZEEL 440.80 EICHERMOT 20335.00 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

3. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NIFTY SPOT MARKET MOVERS UPSIDE TREND BEARISH STRATEGY SCRIPT CLOSE (%) 2.56 BHEL 70.10 PIVOT POINTS S3 10721 S2 10807 R1 10942 R2 10979 R3 11065 2.19 REC 128.25 10856 10893 2.23 GAIL 332.75 S1-10856 S2-10807 R1-10942 R2-10979 1.99 BPCL 354.15 MARKET MOVERS DOWNSIDE CLOSE (%) -6.61 SUNPHARMA -3.70 YESBANK -3.01 FEDERAL BANK -2.50 ZEEL NET BUY (CR.) NET STRATEGY SELL ON RISE SELL (CR) BEARISH 38364.31 PIVOT POINTS P 27538 S3 S1 27409 R1 R3 28119 DII 26957 27248 27699 27828 RESISTANCE NSE TOTALS ADVANCE BANK NIFTY S NIFTY BANK NIFTY 8 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

4. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report MARKET TALKS ! ! Bank of India to raise funds via Majestic Auto hits 20% upper circuit after Q3 numbers Bank of India announced on Wednesday evening via a regulatory filing that it was raising funds for an issue price of Rs105.75 per equity share (including a premium of Rs95.75 per equity share) in respect of preferential issue of shares for an amount of Rs10, 086cr to Government of India. The Bank will allot up to 95, 37, 58,865 fresh equity shares to the Government of India. Shares of Majestic Auto hit the 20% upper circuit on the BSE on Thursday after the company announced its Q3FY19 numbers. The company has reported a net profit of Rs19cr in the quarter ended December 2018 as against a net loss of Rs1.4cr in the previous quarter ended December 2017. Majestic Auto's sales in the quarter, meanwhile, rose 158.7% to Rs35.8cr as against Rs13.8cr in the corresponding quarter of the previous fiscal. ! Mindtree gains 3% post Q3FY19 results Shares of Mindtree soared 3% after the IT Consultancy Company reported revenue in USD terms came in at $251.5mn, up 2.1% qoq. Revenue in Indian rupee terms grew 1.8% qoq to Rs1, 787cr, lower than the median consensus estimate of Rs1, 808cr. EBIT stood at Rs242cr, up 5.5% qoq, higher than the median consensus estimate of Rs240cr. EBIT margin expanded 48bps qoq to 13.6%. The company PAT in the quarter declined 7.3% qoq to Rs191cr, higher than the median consensus estimate of Rs190cr. ! Zydus receives final USFDA approval for Acetazolamide ER capsules Zydus Cadila has received the final approval from the US Food and Drug Administration (FDA) to market Acetazolamide ER Capsules (US RLD-Diamox). It will be manufactured at the groups formulations manufacturing facility at Moraiya, Ahmedabad. Acetazolamide is a potent carbonic anhydrase inhibitor. Acetazolamide ER capsules are used to treat certain types of glaucoma (caused by increased ocular pressure) and to treat or prevent altitude sickness (acute mountain sickness). Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

5. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. Daily Equity Report NAME OF THE STOCK : BIOCON DATE : 18/01/2019 SEGMENT : CASH CHART TYPE : Candlestick EXCHANGE : NSE TECHNICAL INDICATORS USED : VOLUME.MACD,RSI. CHART INVESTMENT ADVICE: CALL CS CALL :- BUY BIOCON IN CASH ABOVE 660 TGT 672 SL 648 RATIONALE FOR ARRIVING INVESTMENT ADVICE : TECHNICAL VIEW : THE STOCK TECHINCALLY IS UP ,TAKING SUPPORT OF VOLUME.RESISTANCE IS BROKEN TODAY WITH HEAVY VOLUME.AS WELL AS A POSSIBILITY OF TREND REVERSAL IS THERE. OTHER REASON IF ANY :- SHOWING STRENGTHS IN INTRADAY CHARTS AS WELL WEDGE PATTERN BREAKOUT. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

6. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. DISCLAIMER The information and views in this report & all the service we provide are believed to be reliable, but we do not accept any responsibility for errors of fact or opinion. Investors have the right to choose the product/s that suits them the most. Sincere efforts have been made to present the right investment perspective. The information contained herein is based on analysis and up on sources that we consider reliable. This material is for personal information and based upon it & takes no responsibility. The information given herein should be treated as only factor, while making investment decision. The report does not provide individually tailor-made investment advice. My research recommends that investors independently evaluate particular investments and strategies, and encourages investors to seek the advice of a financial adviser. Capitalstars shall not be responsible for any transaction conducted based on the information given in this report, which is in violation of rules and regulations of regulators. The price projections shown are not necessarily indicative of future price performance. The information herein, together with all estimates and forecasts, can change without notice. It is understood that anyone who is browsing through the site has done so at his free will and does not read any views expressed as a recommendation for which either the site or its owners or anyone can be held responsible for. Investment & Trading in Securities Markets are always subjected to market risk. Capitalstars Financial Research Private Ltd., Reserves all Rights. INVESTMENT AND TRADING IN SECURITIES MARKET IS ALWAYS SUBJECTED TO MARKET RISK. Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

7. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. BRANCH OFFICE Capitalstars Financial Research Private Limited PLOT NO.32, MECHANIC NAGAR EXTENSION,IDA SCHEME NO.54,VIJAYNAGAR INDORE REGISTERED OFFICE PLOT NO.12, SCHEME NO.78 PART-2, VIJAY NAGAR, INDORE Email:-backoffice@capiltalstars.in Contact us :- 9977499927, 9039012727 Report Is Checked by Investment Advisor: Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.

8. CAPITALSTARS FINANCIAL RESEARCH PVT. LTD. CapitalStars Financial Research Private Limited is an advisory company incepted with a vision of providing fair and accurate trading and investment calls in share and commodity market. we specialize in thorough fundamental and technical research analysis in equity and commodity market to provide best equity and commodity tips to traders and investors. we provide intraday as well as delivery stock tips in NSE and BSE and commodity tips in MCX and NCDEX. Get our more services:- Intraday stock tips Financial advisory company Share market company Stock Tips * Investment & Trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance. * CapitalStars Investment Adviser: SEBI Registration Number: INA000001647 Investment & trading in securities market is always subjected to market risks, past performance is not a guarantee of future performance.